These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8558101)

  • 1. Further clinical studies of curdlan sulfate (CRDS)--an anti-HIV agent.
    Gordon M; Guralnik M; Kaneko Y; Mimura T; Goodgame J; Lang W
    J Med; 1995; 26(3-4):97-131. PubMed ID: 8558101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I study of curdlan sulfate--an HIV inhibitor. Tolerance, pharmacokinetics and effects on coagulation and on CD4 lymphocytes.
    Gordon M; Guralnik M; Kaneko Y; Mimura T; Baker M; Lang W
    J Med; 1994; 25(3-4):163-80. PubMed ID: 7996061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curdlan sulfate (CRDS) in a 21-day intravenous tolerance study in human immunodeficiency virus (HIV) and cytomegalovirus (CMV) infected patients: indication of anti-CMV activity with low toxicity.
    Gordon M; Deeks S; De Marzo C; Goodgame J; Guralnik M; Lang W; Mimura T; Pearce D; Kaneko Y
    J Med; 1997; 28(1-2):108-28. PubMed ID: 9249617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the V2, V3, and CD4-binding domains of GP120 in curdlan sulfate neutralization sensitivity of HIV-1 during infection of T lymphocytes.
    Jagodzinski PP; Wustner J; Kmieciak D; Wasik TJ; Fertala A; Sieron AL; Takahashi M; Tsuji T; Mimura T; Fung MS; Gorny MK; Kloczewiak M; Kaneko Y; Kozbor D
    Virology; 1996 Dec; 226(2):217-27. PubMed ID: 8955041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increases in T cell telomere length in HIV infection after antiretroviral combination therapy for HIV-1 infection implicate distinct population dynamics in CD4+ and CD8+ T cells.
    Kaushal S; Landay AL; Lederman MM; Connick E; Spritzler J; Kuritzkes DR; Kessler H; Levine BL; St Louis DC; June CH
    Clin Immunol; 1999 Jul; 92(1):14-24. PubMed ID: 10413649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART.
    Pandolfi F; Pierdominici M; Marziali M; Livia Bernardi M; Antonelli G; Galati V; D'Offizi G; Aiuti F
    Clin Immunol; 2000 Mar; 94(3):153-9. PubMed ID: 10692234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coinfection with hepatitis C virus increases lymphocyte apoptosis in HIV-infected patients.
    Núñez M; Soriano V; López M; Ballesteros C; Cascajero A; González-Lahoz J; Benito JM
    Clin Infect Dis; 2006 Nov; 43(9):1209-12. PubMed ID: 17029144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zidovudine and lamivudine: results of phase III studies.
    Staszewski S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S57. PubMed ID: 8595510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse correlation between CD8+ lymphocyte apoptosis and CD4+ cell counts during potent antiretroviral therapy in HIV patients.
    Grelli S; d'Ettorre G; Lauria F; Montella F; Di Traglia L; Lichtner M; Vullo V; Favalli C; Vella S; Macchi B; Mastino A
    J Antimicrob Chemother; 2004 Mar; 53(3):494-500. PubMed ID: 14963063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 1 trial of a single dose of recombinant human interleukin-12 in human immunodeficiency virus-infected patients with 100-500 CD4 cells/microL.
    Jacobson MA; Hardy D; Connick E; Watson J; DeBruin M
    J Infect Dis; 2000 Oct; 182(4):1070-6. PubMed ID: 10979901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curdlan sulfate and HIV-1. I. In vitro inhibitory effects of curdlan sulfate on HIV-1 infection.
    Aoki T; Kaneko Y; Stefanski MS; Nguyen T; Ting RC
    AIDS Res Hum Retroviruses; 1991 Apr; 7(4):409-15. PubMed ID: 1676899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensification of a suppressive HAART regimen increases CD4 counts and decreases CD8+ T-cell activation.
    Kolber MA; Saenz MO; Tanner TJ; Arheart KL; Pahwa S; Liu H
    Clin Immunol; 2008 Mar; 126(3):315-21. PubMed ID: 17997138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7.
    Beq S; Bugault F; Colle JH; Lambotte O; Delfraissy JF; Thèze J
    Eur Cytokine Netw; 2005 Dec; 16(4):293-9. PubMed ID: 16464744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection.
    Jacobson JM; Lederman MM; Spritzler J; Valdez H; Tebas P; Skowron G; Wang R; Jackson JB; Fox L; Landay A; Gilbert MJ; O'Neil D; Bancroft L; Al-Harthi L; Jacobson MA; Merigan TC; Glesby MJ;
    J Infect Dis; 2003 Dec; 188(12):1804-14. PubMed ID: 14673758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral immunomodulator Dzherelo in TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOTS.
    Nikolaeva LG; Maystat TV; Pylypchuk VS; Volyanskii YL; Masyuk LA; Kutsyna GA
    Int Immunopharmacol; 2008 Jun; 8(6):845-51. PubMed ID: 18442788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two years of IL-2 in early HIV disease--fantastic increases in CD4+ cell counts.
    TreatmentUpdate; 1999 Mar; 11(2):4-5. PubMed ID: 11366777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
    Oxenius A; Price DA; Günthard HF; Dawson SJ; Fagard C; Perrin L; Fischer M; Weber R; Plana M; García F; Hirschel B; McLean A; Phillips RE
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13747-52. PubMed ID: 12370434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in T-cell subpopulations during four years of suppression of HIV-1 replication in patients with advanced disease.
    Lepej SZ; Begovac J; Vince A
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):351-9. PubMed ID: 16553807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CD8+ cell noncytotoxic antiviral response (CNAR) to HIV in nosocomial HIV-infected individuals].
    Yuan L; Ma LY; Zang XH; Meng XD; Peng H; Zhao QB; Xing H; Shao YM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):195-7. PubMed ID: 19031701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.